Top Markets
Coin of the day
Caliway Biopharmaceuticals Co. L Caliway Biopharmaceuticals Co. L

Caliway Biopharmaceuticals Co. L

6919
Classement en actions #3557
Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated... Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated to developing pharmaceuticals primarily in the fields of aesthetic medicine and chronic inflammation. Its lead investigational drug, CBL-514, is currently undergoing Phase 2 clinical trials, targeting non-surgical fat reduction, Dercum's disease, and cellulite. Beyond this, the firm is also progressing CBA-539 through preclinical exploration for potential applications in central obesity, hyperpigmentation, and skin aging. The company's offerings also extend to dietary supplements. Established in 2012, Caliway Biopharmaceuticals operates from its headquarters in New Taipei City, Taiwan.
Prix de l'action
$3.28
Dernière synchronisation: 2026-07-31
Capitalisation boursière
$5.10B
Changement (1 jour)
0.00%
Changement (1 an)
-49.70%
Pays
TW
Échange Caliway Biopharmaceuticals Co. L (6919)

Catégorie

Historique des divisions d’actions pour Caliway Biopharmaceuticals Co. L (6919)
L’action Caliway Biopharmaceuticals Co. L (symbole : 6919) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 26, 2026.
Une action 6919 achetée avant le Aug 26, 2026 équivaudrait aujourd’hui à 0 actions 6919.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH